PH-10 radiosensitizer regulatory update

PHGN received U.S. Patent No. 6,331,286 covering the use of PH-10 as a radiosensitizer to enhance therapeutic effects and diminish side effects of radiation therapy. Topical PH-10 is in Phase I testin...